400-888-1571 首页 购物车
Expert Opinion On Pharmacotherapy

Expert Opinion On Pharmacotherapy

药物治疗专家意见

  • 3区 中科院分区
  • Q3 JCR分区
期刊首页 期刊评价 发文分析 高引用文章 了解投稿 期刊咨询

期刊简介

《Expert Opinion On Pharmacotherapy》是由Taylor and Francis Ltd.出版社于1999年创办的英文国际期刊（ISSN: 1465-6566，E-ISSN: 1744-7666），该期刊长期致力于药学领域的创新研究，主要研究方向为医学-药学。作为SCIE收录期刊（JCR分区 Q3，中科院 3区），本刊采用OA未开放获取模式（OA占比0.0370...%），以发表药学领域等方向的原创性研究为核心（研究类文章占比26.97%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在152篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Expert Opinion On Pharmacotherapy审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单，年发文量约152篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 否 是否预警
  • SCIE 期刊收录
  • 152 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
否 是
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
否 是
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科：PHARMACOLOGY & PHARMACY SCIE Q3 180 / 354

49.3%
按JCI指标学科分区 收录子集 分区 排名 百分位
学科：PHARMACOLOGY & PHARMACY SCIE Q3 227 / 354

36.02%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore：5.6 SJR：0.687 SNIP：0.747
学科类别 分区 排名 百分位
大类：Medicine 小类：Pharmacology (medical) Q2 89 / 272

67%
大类：Medicine 小类：Pharmacology Q2 136 / 313

56%

期刊发文

  • An evaluation of sodium zirconium cyclosilicate: a new treatment option for hyperkalaemia in China

    Author: Lu, Yuan; Liu, Bi-Cheng; Liu, Hong

    Journal: EXPERT OPINION ON PHARMACOTHERAPY. 2023; Vol. 24, Issue 3, pp. 301-308. DOI: 10.1080/14656566.2022.2161884

  • Emerging sodium-glucose cotransporter-2 inhibitor therapies for managing heart failure in patients with chronic kidney disease

    Author: Chan, Jeffrey Shi Kai; Perone, Francesco; Bayatpoor, Yasmin; Tse, Gary; Harky, Amer

    Journal: EXPERT OPINION ON PHARMACOTHERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14656566.2023.2204188

  • The correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

    Author: Jiao, Ruoyang; Lin, Chu; Bai, Shuzhen; Cai, Xiaoling; Hu, Suiyuan; Lv, Fang; Yang, Wenjia; Zhu, Xingyun; Ji, Linong

    Journal: EXPERT OPINION ON PHARMACOTHERAPY. 2023; Vol. 24, Issue 4, pp. 511-521. DOI: 10.1080/14656566.2023.2181693

  • Efficacy and safety of thrombopoietin receptor agonists in children and adults with persistent and chronic immune thrombocytopenia: a meta-analysis

    Author: Li, Ting; Liu, Qinqin; Pu, Ting; Liu, Jing; Zhang, Aijun

    Journal: EXPERT OPINION ON PHARMACOTHERAPY. 2023; Vol. 24, Issue 6, pp. 763-774. DOI: 10.1080/14656566.2023.2198089

  • An evaluation of pitavastatin for the treatment of hypercholesterolemia.

    Author: Chan P1, Shao L2, Tomlinson B3,4, Zhang Y3, Liu ZM5.

    Journal: Expert Opin Pharmacother. 2019 Jan;20(1):103-113. doi: 10.1080/14656566.2018.1544243. Epub 2018 Nov 27.

  • Insight into the perioperative management of direct oral anticoagulants: concerns and considerations.

    Author: Ibrahim A1, Walsh LG2, Algaali M1, Satti Z1, Kiernan TJ3, Yan BP4.

    Journal: Expert Opin Pharmacother. 2019 Mar;20(4):465-472. doi: 10.1080/14656566.2018.1551879. Epub 2018 Dec 6.

  • Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia.

    Author: Ma YB1, Chan P2, Zhang Y3, Tomlinson B3,4, Liu Z5.

    Journal: Expert Opin Pharmacother. 2019 Jun;20(8):917-928. doi: 10.1080/14656566.2019.1594776. Epub 2019 Mar 25.

  • Bivalirudin infusion in patients with acute coronary syndrome after stenting.

    Author: Li W1, Mai L1, Cai X2, Li M1, Huang Y1.

    Journal: Expert Opin Pharmacother. 2019 May 6:1-2. doi: 10.1080/14656566.2019.1615329. [Epub ahead of print]

相关期刊

怎样选择期刊
投稿相关问题
投稿后咨询